The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

Pfizer Inc. PFE on Tuesday announced topline results from the Phase 2 FOURLIGHT-1 study in pretreated metastatic breast ...

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal and rare cancer session and a Society of Urologic Oncology (SUO) lecture ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

Desmoda (desmopressin acetate) Vasopressin 2 receptor agonist Management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. FDA Approves Desmoda Oral ...

France's Servier has emerged as the suitor, with an all-cash offer to buy Day One and its fast-growing brain cancer therapy Ojemda (tovorafenib) for $21.50 per share, valuing the California company at ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Dividend Stocks to Invest in Under $50. On March 2, Argus upgraded ...

At its stand at MWC, which is being held in Barcelona from March 2 to 5, Telefónica will showcase three Quantum-Safe solutions, developed respectively with hardware from Adtran (Data Center ...

Full approval was driven by BREAKWATER Phase III outcomes, including PFS HR 0.53 and OS HR 0.49 versus fluoropyrimidine/oxaliplatin-based chemotherapy options ± ...